Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 4
Original Research
The absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles is not significantly impacted by the use of myeloid growth factors and predicts clinical outcomes in classical Hodgkin lymphoma regardless of their use
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,415 | Dovepress* | 13,415+ | 1,353 | 14,768 | |
Totals | 13,415 | 1,353 | 14,768 | ||
*Since 23 July 2014 +Since July 2016 |
View citations on Google Scholar